The FDA cleared Accuray‘s CyberKnife M6 Series of devices that promise to expand the capabilities of radiosurgery.
The proprietary InCise Multileaf Collimator on the CyberKnife M6 FIM and FM systems is capable of changing its shape, and so the beam that it forms. The arm can approach the target tumor from just about any angle, providing flexibility for treatment planning.
The new CyberKnife M6 FIM and FM Systems, featuring the InCise™ Multileaf Collimator combines the benefits of beam shaping with the flexibility of non-isocentric, non-coplanar delivery offering unmatched clinical capabilities and expanding the number of patients eligible for treatment.
The new InCise Multileaf Collimator was designed specifically for stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) treatments, giving the system the capability to extend its radiosurgical accuracy into a broader field of applications, meeting radiosurgery and radiotherapy needs.
With the new InCise™ Collimator (optional on the FI version), the CyberKnife M6 Series is the only clinical solution to combine the benefits of MLC beam shaping with continual image guidance and non-isocentric, non-coplanar treatment delivery. Precisely sculpting dose to spare healthy tissue while maintaining sub-millimeter accuracy – even for targets that move during respiration – the CyberKnife M6 Series is the clinical solution when accuracy, flexibility, and efficiency are essential.
Indication-specific tumor tracking with automatic correction throughout treatment, true robotic mobility, and advanced collimation integrate seamlessly into the only system to automatically stay on target despite patient and tumor motion.
Product page: CyberKnife M6 Series…